What is Skinfix?
Founded in 2014 by Amy Gordinier, Skinfix operates at the intersection of dermatological science and clean beauty. The company distinguishes itself by offering products that are rigorously tested by unbiased dermatologists, focusing specifically on the maintenance and restoration of the skin barrier. By leveraging historical formulations and modern clinical validation, Skinfix has successfully scaled its operations to address complex skin health needs, including eczema and barrier dysfunction. The brand maintains a strict commitment to fragrance-free, cruelty-free, and vegan-friendly formulations, further bolstered by its Planet Love initiative for sustainable packaging. This unique value proposition has allowed the firm to capture a loyal demographic that prioritizes both ingredient transparency and measurable clinical outcomes.
How much funding has Skinfix raised?
Skinfix has raised a total of $676K across 1 funding round:
Private Equity
$676K
Private Equity (2014): $676K, investors not publicly disclosed
Key Investors in Skinfix
Undisclosed Investor
An undisclosed institutional partner providing strategic backing to support the company's long-term clinical research and market scaling initiatives.
What's next for Skinfix?
With the recent capital deployment, Skinfix is poised to accelerate its enterprise-level growth strategy. The focus will likely shift toward scaling distribution channels and deepening its research and development pipeline to address a broader spectrum of dermatological concerns. As the brand continues to gain traction in the clinical skincare market, the current financing provides the necessary runway to enhance supply chain resilience and expand its footprint in international markets. Investors are closely monitoring how the company will leverage its dermatological credibility to maintain its competitive edge against legacy skincare conglomerates, particularly as consumer demand for clinically-backed, clean-label products continues to rise.
See full Skinfix company page
